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1 Abstract 
Previous studies from our group reported that pancreatic -cells express ryanodine receptors (RyRs) that 
can mediate Ca
2+
-induced Ca
2+
 release (CICR). The full consequences of the activation of RyRs on Ca
2+
 
signaling in these cells, however, remained unclear. An important open question was whether activation of 
the RyRs leads to activation of any Ca
2+
 channels in the plasma membrane, and thereby depolarizes 
membrane potential. One main aim of the thesis was to address this question. As a corollary, we have also 
looked for the existence of functional TRPV1 channels, and have elucidated the molecular mechanisms 
that underlie the [Ca
2+
]i-elevating effect of ADP ribose in these cells.  
We used methods such as measurement of the [Ca
2+
]i in single cells loaded with fura-2, patch 
clamp technique, Western blot analysis, immunohistochemistry, a variety of pharmacological tools, and a 
series of carefully designed protocols. In most experiments, we used S5 cells, derived from the rat 
insulinoma cell line INS-1E, but we also used primary -cells from mice, rat, and human. 
Activation of the RyRs by 9-methyl 5,7-dibromoeudistomin D (MBED) increased the [Ca
2+
]i with 
an initial peak, followed by a decline to a plateau phase, and regenerative spikes superimposed on the 
plateau. The initial [Ca
2+
]i increase was due to the activation of the RyRs in the ER, since it was abolished 
by thapsigargin, but was present when extracellular Ca
2+
 was omitted or when Ca
2+
 entry was blocked by 
SKF 96365. The plateau phase was due to Ca
2+
 entry across the plasma membrane, since it was abolished by 
omission of extracellular Ca
2+
, and blocked by SKF 96365. The plateau phase was not solely dependent on 
the filling state of the ER, since it was not abolished by thapsigargin. Inhibition of the voltage-gated Ca
2+
 
channels by nimodipine did not inhibit the plateau phase. Several agents that block TRP channels, e.g. La
3+
, 
Gd
3+
, niflumic acid, and 2-APB, inhibited the plateau phase. It was also inhibited by membrane 
depolarization. We conclude that the plateau phase was due to activation of some TRP-like channels. 
Activation of RyRs by MBED also induced membrane depolarization. The spikes required Ca
2+
 entry 
through the L-type voltage-gated Ca
2+
 channels, as they were abolished by nimodipine. The spikes resulted 
from CICR, since they were inhibited in a use-dependent way by ryanodine, and abolished after depletion of 
the ER by thapsigargin. Thus, activation of RyRs activated TRP-like channels, depolarized the plasma 
membrane, activated L-type voltage-gated Ca
2+
 channels and triggered CICR. 
During the course of this thesis we reported that TRPM2 is present in the INS1-E cells and the 
human -cells. We studied whether TRPM2 was involved in the Ca2+ entry triggered by the activation of 
RyRs. N-(p-amylcinnamoyl) anthranilic acid (ACA), an inhibitor of TRPM2, did not inhibit the MBED-
induced [Ca
2+
]i entry. ADP ribose (ADPr), when applied intracellularly, is an agonist of TRPM2. We found 
that extracellularly applied ADPr increased [Ca
2+
]i in the form of an initial peak followed by a plateau that 
depended on extracellular Ca
2+
. EC50 of ADPr was ~30 µM. NAD
+
, cADPr, a phosphonate analogue of 
ADPr (PADPr), 8-bromo-ADPr or breakdown products of ADPr did not increase [Ca
2+
]i. Inhibitors of 
TRPM2, e.g. flufenamic acid, niflumic acid, and ACA did not affect the ADPr-induced [Ca
2+
]i increase. 
Two specific inhibitors of the purinergic receptor P2Y1, e.g. MRS 2179 and MRS 2279 completely blocked 
the ADPr-induced [Ca
2+
]i increase. The [Ca
2+
]i increase by ADPr required activation of PI-PLC, since the 
PI-PLC inhibitor U73122 abolished the [Ca
2+
]i increase. The ADPr-induced [Ca
2+
]i increase was through the 
IP3 receptors, since it was inhibited by 2-APB, an inhibitor of the IP3 receptors. ADPr increased [Ca
2+
]i in the 
transfected human astrocytoma cells that expressed the P2Y1 receptors, but not in the wild type astrocytoma 
cells. We conclude that extracellular ADPr is an endogenous and specific agonist of P2Y1 receptors.  
Capsaicin and AM404, two specific agonists of TRPV1, increased [Ca
2+
]i in the INS-1E cells. 
Capsazepine, a specific antagonist of TRPV1, completely blocked the capsaicin-induced [Ca
2+
]i increase. 
Capsaicin elicited inward currents that were abolished by capsazepine. TRPV1 protein was detected in the 
INS-1E cells and human -cells by Western blot. However, no TRPV1 immunoreactivity was detected in 
the human islet cells and human insulinoma by immunohistochemistry. Capsaicin did not increase [Ca
2+
]i in 
primary -cells from rat or human. We conclude that INS-1E cells express functional TRPV1 channels.  
In summary, we have shown that (1) RyR activation leads to activation of TRP-like channels in the 
plasma membrane, membrane depolarization, activation of L-type voltage-gated Ca
2+
 channels and CICR. 
(2) ADPr is a specific and endogenous low affinity ligand for the P2Y1 receptors. (3) Functional TRPV1 
channels are expressed in the INS-1E cells, but not in the primary -cells.  
 
Keywords: Ca
2+
 signaling, signal transduction, islets of Langerhans,-cells,  ryanodine receptors, Ca2+-
induced Ca
2+
 release, TRP-channels, TRPV1, capsaicin, P2Y1 receptors, and ADP ribose.  
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2 Erratum 
 
Paper IA: page 302, paragraph 2, line 10: -40 mV, not -40 mM.  
 
Paper IB: page 4, line 38: -40 mV, not -40 mM, 
page 3, line 4; page 4, line 13; page 13, figure legend 1, line 6: Wistar rat, not Wister rat. 
 
Paper II: fig. 3C: The concentrations are in µM, not mM. 
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4 List of abbreviations 
    
ACA 
ADPr 
N-(p-amylcinnamoyl) anthranilic acid 
Adenosine diphosphate ribose 
AM Acetoxymethyl ester 
AM404 N-(4-hydroxyphenyl)-arachidonoylamide 
AMP Adenosine monophosphate 
ATP Adenosine triphosphate 
BSA Bovine serum albumin 
cADPr Cyclic adenosine diphosphate ribose 
cAMP Adenosine 3´5´-cyclic monophosphate 
CICR Ca
2+
-induced Ca
2+
 release 
DAG Diacylglycerol 
DMSO Dimethyl sulfoxide 
EGTA Ethylene glycol tetraacetic acid 
ER Endoplasmic reticulum 
GLP-1 
HBSS 
Glucagon-like peptide 
Hank’s balanced salt solution 
ICRAC 
IP3 
Ca
2+
 release activated Ca
2+
 current 
Inositol 1,4,5-trisphosphate 
IP3R Inositol 1,4,5-trisphosphate receptor 
KATP channel ATP-sensitive potassium channel 
KRBH Krebs Ringer bicarbonate HEPES buffer 
NAADP 
NAD
+ 
Nicotinic acid adenine dinucleotide phosphate 
Nicotinamide adenine dinucleotide 
NADP
+
 
Orai1 
P2Y1 
PIP2 
Nicotinamide adenine dinucleotide phosphate 
A pore forming subunit of the mammalian CRAC channel 
Purinergic receptor type 2Y1 
Phosphatidylinositol 4,5-bisphosphate 
PKA cAMP-dependent protein kinase 
PKC Protein kinase C 
PI-PLC Phosphoinositide-specific phospholipase C 
PMCA 
RPM 
Plasma membrane Ca
2+
 ATPase 
Revolutions per minute 
RPMI Roswell Park Memorial Institute medium 
RyR Ryanodine receptor 
SERCA Sarco(endo)plasmic reticulum Ca
2+
-ATPase 
SOCE 
STIM1 
TRP 
Store-operated Ca
2+
 entry 
Stromal interaction molecule 1 
Transient receptor potential 
TRPM2 Transient receptor potential melastatin 2 
TRPV1 Transient receptor potential vanilloid 1 
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5 Introduction and Background 
 
5.1 The islets of Langerhans  
 
The islets of Langerhans, named after the German pathologist Paul Langerhans, is a 
critical organ unique in that it is split into about a million units hidden in the pancreas. In 
1869 Langerhans described small, clearer areas in the pancreas that stained differently 
from the rest of the pancreas. He thought that these structures were lymphatic tissues. 
Others thought that these could be embryonic remnants. These were named “islets of 
Langerhans” by the French histologist Gustave-Edouard Laguesse 24 years later. He 
suggested that the structures formed the endocrine part of the pancreas with a possibility 
to produce a hormone with glucose-lowering effect (1).  
 
The islets have an essential role in regulation of the glucose homeostasis. The glucose 
concentration in the plasma is kept in a narrow interval irrespective of food intake or 
starving situation, by a fine-tuning system where the plasma glucose-lowering hormone 
insulin is antagonized by glucagon. The location of the islets is advantageous, since the 
hormones are secreted into the portal vein enabling direct control of the hepatic function. 
Impaired function or destruction of the cells in the islets underlies pathogenesis of 
different forms of diabetes, which is a public health problem throughout the world.  
 
In humans, islets of Langerhans are spherical clusters of cells with a diameter 
between ~50-250 µm (2). The total number of islets varies depending on age, body 
mass index, size of the pancreas, and conditions such as pregnancy (3). They are in 
a higher number in the tail than in the head and body of the pancreas (4). The 
number of islets increases as the diameter of the islets decreases (5). Most of the 
islets are of small diameter, i.e. ~50-100 µm. However, medium sized islets with a 
diameter of ~100-200 µm contribute most to the total islet volume at all ages with 
the exception of the newborn, where it is the opposite (5). The islets of patients 
who have diabetes can be very large, up to ~350 µm in diameter, because of 
oedema and deposition of amyloid (2).  
 
There are three major types of cells in the islets, i.e. the -, -, and -cells. In addition, 
there are other minor cell types, e.g. the pancreatic polypeptide-secreting (PP)-cells, the -
cells, and the dendritic cells. Most of the cells (70-80%) in the adult human islets are 
insulin-secreting β-cells. Among the remaining are 15-20% glucagon-secreting α-cells, 5-
10% δ-cells, 1% -cells (6), and 1% PP-cells. -cells secrete somatostatin and possibly 
gastrin. -cells secrete ghrelin, which stimulates growth hormone release and apetite (7). 
In each islet there are 5-20 dendritic cells, which express class II antigen with 
phagocytotic capacity (8). In addition to insulin, the -cells secrete islet amyloid 
polypeptide (IAPP). However, all -cells do not secrete IAPP since only 54% of -cells 
stain for IAPP (2). 
 
TRP channels and intracellular Ca
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The islets coordinate their work even though they are structurally separated. A -cell 
communicates with another through paracrine mechanisms or via a local vascular system 
within the islet. There is electrical synchronization between -cells through gap junctions. 
Also, the -cells communicate with non--cells via gap junctions. The gap junctions are 
made of connexin36, which is important for the oscillation of insulin secretion (9;10).  
 
Today, there are about 285 million people in the world with overt islet failure (11). By the 
year of 2030, the number is likely to increase to 438 million. A gradual decrease in 
function of the islets takes place over years, and it is not until as much as 90% of the islets 
have stopped to function or are destroyed that any decline in health is noticed. 
 
 
5.2 Insulin secretion  
 
When studying -cells, it is common to assume that they have a resting state when they 
do not secret insulin, and a stimulated state when they do. However, under physiological 
conditions, large insulin secretion occurs even under the fasting state, and secretion 
increases after food intake. In human, about 75% of the insulin secretion occurs in the 
form of oscillations with an interpulse interval of about five minutes (12;13). The pulsatile 
pattern of insulin secretion, which has many physiological advantages, is lost in patients 
with type 2 diabetes. The insulin secretion is regulated by the amplitude rather than the 
frequency of insulin oscillation. The synchronization signals for insulin secretion from a 
large number of islets are unclear, but neural networks are thought to be important in this 
process. 
  
After a meal, the concentrations of nutrients including glucose, amino acids, and free fatty 
acids in the plasma increase, and the amplitude of insulin pulses increases. To trigger 
insulin secretion, glucose needs to be metabolized by glucokinase. Some mutations in the 
glucokinase gene can cause maturity onset diabetes of the young (MODY) (14). 
Metabolism of pyruvate and ATP production in the mitochondria are essential for 
glucose-stimulated insulin secretion. Several other factors generated from the 
mitochondria also potentiate insulin secretion. Some uncommon forms of diabetes are due 
to mutations or deletions in mitochondrial DNA.  
 
A [Ca
2+
]i increase is an essential trigger for insulin exocytosis. Insulin secretion is also 
regulated by neurotransmitters, and incretin hormones secreted from the gut. Glucagon 
like peptide 1 (GLP-1) is one important incretin hormone that augments insulin secretion, 
somatostatin secretion, and inhibits glucagon secretion. Furthermore, it promotes -cell 
survival and proliferation. These actions of GLP-1 are mediated by Ca
2+
 as well as cyclic 
AMP (cAMP), and other signaling pathways. Thus, the insulin secretion is a highly 
controlled process that involves multiple nutrients, neurotransmitters, and hormones. 
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5.3 Ca2+ signaling in the -cells 
The calcium of importance for intracellular signaling is the ionized form of calcium, Ca
2+
, 
inside the cell. Changes in the cytosolic free Ca
2+
 concentration ([Ca
2+
]i) induces signals 
for various cellular processes. Many Ca
2+
-binding proteins, membranes, channels, pumps, 
stores, and other organelles are involved in the generation, and shaping of the Ca
2+
 
signals. The Ca
2+
 signals in the -cells control exocytosis of insulin. In a “resting” -cell 
in vitro, the [Ca
2+
]i is ~ 20-100 nM, and outside the cells the Ca
2+
 concentration is 10 000 
times higher.  
 
To avoid toxicity, the [Ca
2+
]i must return to a resting level, and this is achieved by the 
plasma membrane Ca
2+
 ATPases (PMCA) that pumps out Ca
2+
 from the cytoplasm. Also, 
there are Na
+
/Ca
2+
 exchangers for lowering [Ca
2+
]i. The ATP-driven pumps have high 
affinity but low capacity, compared to the exchangers that take care of the large Ca
2+
 
loads. In Ca
2+
 signaling the [Ca
2+
]i increases, and returns to the resting level shortly after. 
The [Ca
2+
]i increase is likened to pressing the on-button, and a decrease in [Ca
2+
]i means 
that the off-button is pressed. 
 
Other molecules that are involved in Ca
2+
 signaling include Ca
2+
 binding proteins, Ca
2+
 
channels, Ca
2+
 mobilizing messengers, and Ca
2+
-sensing molecules. Calmodulin is a Ca
2+
 
binding protein present in almost all cells. It contains a single polypeptide chain of 150 
amino acids with four Ca
2+
 binding sites. Calmodulin constitutes about 1% of the total 
protein mass of the -cells. Besides [Ca2+]i regulation, calmodulin mediates many Ca
2+
 
regulated processes in the cell, and works as a multipurpose intracellular Ca
2+
 receptor. 
The binding of Ca
2+
 enables calmodulin to bind to various target proteins, and alter their 
activity. Ca
2+
/calmodulin binds to, and activates the PMCA that pumps Ca
2+
 out of the 
cell. Most effects of Ca
2+
/calmodulin are mediated by the Ca
2+
/calmodulin-dependent 
kinases.  
 
In the plasma membrane there are different Ca
2+
 channels: voltage-gated, receptor-
activated, and channels belonging to the “transient receptor potential” (TRP) family. 
Glutamate receptors and purinergic receptors of P2X type are examples of receptor-
activated channels that are present in many cells. IP3 is the most well characterized Ca
2+
 
mobilizing intracellular messenger. Others are cADPr and nicotinic acid adenine 
dinucleotide phosphate (NAADP). Together, all the molecules involved in Ca
2+ 
signaling 
in the -cells orchestrate the [Ca2+]i to fine-tune the insulin secretion.  
 
TRP channels and intracellular Ca
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Figure 1. The figure shows some of the molecules involved in Ca
2+
 signaling in the
-cell. The figure also shows a mechanism for Ca2+ induced Ca2+ release (CICR). DAG = 
diacylglycerol; ER = endoplasmic reticulum; Glu = glucose; GLUT = glucose transporter; 
IP3 = inositol 1,4,5-trisphosphate; IP3R = inositol 1,4,5-trisphosphate receptor; RyR = 
ryanodine receptor; SG = secretory granulae; PI-PLC = phosphatidyl inositol specific 
phospholipase C; PMCA = plasmamembrane Ca
2+
ATPase; ROC = receptor activated 
channel; SERCA = sacro(endo)plasmic reticulum Ca
2+
ATPase. 
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5.3.1 Ca2+ oscillations 
The [Ca
2+
]i increase often takes place in the form of oscillations. Low concentration of an 
agonist leads to a low frequency, whereas a higher concentration leads to a higher 
frequency of the oscillations. The advantage of Ca
2+ 
oscillations compared to 
continuously increased [Ca
2+
]i is that the cells are not damaged by Ca
2+
 when the [Ca
2+
]i 
oscillates. There is also a less likelihood of desensitization of the intracellular Ca
2+
 
sensors. The -cells interpret the Ca2+ signals by the degree of [Ca2+]i increase or the 
frequency of Ca
2+
 oscillations. It has been shown that Ca
2+
 oscillations increase the 
efficiency, and the information content of Ca
2+
 signals that lead gene expression. In -
cells, at least three different types of Ca
2+
 oscillation have been described (15). The 
mechanism involved in the formation and decoding of Ca
2+
 oscillations is an active 
research field. Perturbed oscillations may be a cause for impaired insulin release that is 
normally pulsatile possibly because of the Ca
2+
 oscillations (16). 
 
 
5.4 Stimulus-secretion coupling in the -cells 
The main triggers for insulin secretion from the -cells are nutrient-induced [Ca2+]i 
increases. Glucose is transported into the -cell through a facilitative glucose transporter 
(GLUT1 and 3 in humans, and GLUT 2 in rodents) (17;18). Glycolysis, and metabolism 
in the mitochondria increases ATP/ADP ratio (19;20). The cytoplasmic ATP/ADP ratio 
acts as intracellular messenger that couples nutrient metabolism to electrical activity of -
cells. In this respect, the ATP-sensitive potassium channel (KATP channel) acts as a sensor 
of cellular metabolism. KATP channels of -cells consist of two subunits, the channel 
subunit KIR6.2, and the sulfonylurea receptor SUR1. These channels are inhibited by, and 
are targets for the insulin-lowering sulfonylurea drugs (21). The KATP channels can be 
activated by agents such as MgADP and diazoxide, by involvement of the two nucleotide 
binding folds (NBF) 1, and 2 of SUR1 (22). This leads to hyperpolarization of the plasma 
membrane. When plasma glucose concentrations are reduced, a decreased ATP/ADP ratio 
leads to opening of the KATP channels, and causes repolarization. In this way, insulin 
secretion, and hypoglycaemia is prevented. Closure of the KATP channels is an initial 
signaling event leading to membrane depolarization. It should be emphasized, however, 
that closure of the KATP channels alone is not sufficient to depolarize the cell. That needs a 
co-existing inward depolarizing current. These depolarizing currents through as yet 
unknown channels depolarize the plasma membrane when the KATP channels are closed. 
It has been suggested that some TRP channels may account for these currents. 
 
 
5.5 Transient receptor potential channels 
The TRP channels were discovered in the photoreceptor cells of blind fruit flies (23). The 
light-induced change of membrane potential in these cells was transient rather than 
sustained. This was due to a mutation of a channel, thus called the transient receptor 
potential channel. There are 28 (27 in human) TRP channels, and one or other TRP 
channels are present in almost all cells. They are diverse when it comes to the regulation 
and function. The TRP channels are tetrameric ion channels that may form both homo- 
TRP channels and intracellular Ca
2+
 channels of -cells 
 
17 
 
and heterotetramers, and this gives possibilities for formation of many different channels. 
TRP channels mediate many sensory functions. The channels are divided into two groups 
according to their molecular similarities. Group 1 has five subfamilies. There are seven 
TRP channels related to the classical or canonical channel (TRPC). These channels are 
the most related to the original TRP channels. There are six TRP channels related to the 
vanilloid receptor (TRPV), and eight TRP channels related to the melastatin subfamily 
(TRPM). There are also TRPA channels, with many ankyrin repeats, and TRPN channels 
(24).  
 
Group 2 TRP channels consist of two subfamilies: TRPP and TRPML. Mutations in the 
TRPP channels cause autosomal dominant polycystic kidney disease. Mutation in 
TRPML causes the neurodegenerative disorder mucolipidosis type IV. 
 
We studied the mechanisms of RyR-activated membrane depolarization. TRP channels 
are known to mediate membrane depolarization in many cells (25;26). Therefore, we 
studied whether TRP channels were involved in the RyR-activated membrane 
depolarization in the -cells. 
 
5.5.1  TRP channels in the -cells 
At the beginning of this thesis, there was scanty information in the literature about TRP 
channels in the -cells. During subsequent years, research from many groups has shown 
that many TRP channels are present in the -cells. These are TRPC1-6 (27-29), TRPM2-5 
(30-34), and TRPV1, 2, and 4 (35-37). Two of these have been dealt with in this thesis, 
and these will be discussed further. It is possible that some of the TRP channels mediate 
the inward depolarizing currents in the -cells. The depolarization leads to activation of 
voltage-gated Ca
2+
 channels, and influx of Ca
2+
.  
 
5.5.1.1 TRPM2 channels 
The type 2 melastatin-like transient receptor potential (TRPM2) is a chanzyme, forming 
a non-selective cation channel permeable to Na
+
, K
+
, and Ca
2+
 (38). The C-terminal of 
TRPM2 has an ADPr pyrophosphatase domain (38;39). TRPM2 expression is highest in 
the brain, but several peripheral cell types also express TRPM2 (40).TRPM2 functions 
as a cellular redox sensor, and TRPM2 activation leads to apoptosis and cell death 
(41;42).  
 
TRPM2 is also activated by ADP ribose, NAD
+
, nitric oxide, arachidonic acid, 
temperatures >35 ºC and Ca
2+
. TRPM2 can be activated by Ca
2+
 released from the 
intracellular stores (43). N-(p-amylcinnamoyl) anthranilic acid (ACA) is an inhibitor of 
TRPM2, but it is not so specific. Flufenamic acid, the antifungal agents miconazole and 
clotrimazole are also inhibitors of TRPM2 (44;45). Whether 2-APB inhibits TRPM2 is 
controversial (46;47) Our group has shown that in the human islets, there are at least two 
main isoforms of TRPM2 channels: one is the full-length form (TRPM2-L) and the other 
is a nonfunctional form because of C-terminal truncation (TRPM2-S) (48). TRPM2 is 
mainly located in the plasma membrane and allows Ca
2+
 entry. However, TRPM2 is also 
located on the lysosomal membranes Activation of TRPM2 releases Ca
2+
 from the 
lysosomes (49). We have shown that functional TRPM2 channels are present in the INS-
1E cells and the human -cells (fig. 2) (30).  
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Figure 2. Whole-cell currents induced by ADPr and H2O2 in INS-1E cells. The figure 
is reproduced from Bari et al 2009 with permission. The whole-cell configuration was 
attained at the point indicated with “w.c.”. Recordings were performed at room 
temperature and the holding potential was -60 mV. Bars indicate times where the standard 
bath solution was changed to a solution containing ACA, a TRPM2 inhibitor, or N-
methyl-D-glucamine (NMDG
+
), which is impermeable to TRPM2. Whole-cell current 
was recorded in the presence of intracellular ADPr. The pipette solution contained 0.6 
mM ADPr and 1µM Ca
2+
 (A). Whole cell currents recorded without ADPr and after 
application of 1-2 µl 30% H2O2 directly into the recording chamber. The estimated final 
concentration of H2O2 in the chamber was ~10 mM. The pipette solution contained 1 µM 
free Ca
2+
 (B). Current-voltage relationship of H2O2-induced currents as derived from (B), 
recorded during voltage ramps from -90 to +60 mV of 400 ms duration (C). 
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5.5.1.2 TRPV1 channels 
TRPV1 is a non-selective cation channel that mediates peripheral nociception and pain 
sensation. It is abundant in the trigeminal and the dorsal root ganglia. TRPV1 positive 
afferent neurons have been claimed to play a critical role in local islet inflammation in 
autoimmune diabetes pathoetiology (50). One group has reported that TRPV1 protein is 
expressed in the rat insulinoma cell lines RIN and INS-1 (35). Whether TRPV1 exists in 
the primary -cells remains controversial. TRPV1 immunoreactivity has been described 
in primary -cells of Sprague-Dawley rats by one group (35), but not in those of Zucker 
diabetic rats (51) or NOD mice (50). It is not known whether TRPV1 is present in the 
human -cells. 
 
Capsaicin, resiniferatoxin, temperature >43 ºC and low pH are some of the activators of 
TRPV1 (52). Capsaicin is the pungent component of chili pepper. It produces burning 
pain, desensitisation and degeneration of a specific subset of sensory fibres that are also 
sensitive to chemical irritants and noxious heat. This explains the burning sensation of 
chili pepper intake. Due to desensitization of nociceptive terminals, capsaicin also 
exhibits analgesic properties. Capsaicin is lipophilic and binds to the intracellular part of 
TRPV1 and thereby activates the TRPV1 channel (53;54).  
 
TRPV1 is expressed in nerve fibres in the islets of Langerhans of rats and mice (50;51). 
Akiba et al have reported that TRPV1 protein is expressed in the rat insulinoma cell 
lines RIN and INS-1, and that insulin secretion is increased by capsaicin in the RIN 
cells (35). We have studied whether TRPV1 activation leads to [Ca
2+
]i increase or 
induces currents in the -cells. 
 
We have used capsaicin and AM404 as agonists of TRPV1. The active metabolite of 
paracetamol, AM404 activates TRPV1 at analgesic doses of paracetamol (55;56). After 
ingestion, paracetamol is metabolized into, among others, p-aminophenol. AM404 is 
formed by conjugation of p-aminophenol and arachidonic acid. AM404 is formed in the 
brain by the action of fatty acid amide hydrolase (FAAH) (57). The TRPV1 antagonist 
capsazepine is a synthetic analogue that competitively inhibits capsaicin binding (58). It 
also blocks TRPV1 activation induced by low pH (59). We used capsaicin, AM404 and 
capsazepine as tools for identifying the TRPV1 channel in the -cells. 
 
It is not fully established whether TRPV1 exists in the primary β-cells. Therefore, we 
studied the effect of capsaicin on [Ca
2+
]i in primary rat and human primary β-cells. 
Immunohistochemistry was used to study the expression of TRPV1 protein in the human 
islet cells and the human insulinoma cells. 
 
 
5.6 The role of the endoplasmic reticulum in Ca2+ signaling 
Like many other cells,the-cells have several Ca2+ stores. Among these, the endoplasmic 
reticulum (ER) is the best characterized. The ER is best known for its role in the protein 
synthesis, but it is also a sophisticated instrument for Ca
2+
 signaling. The Ca
2+
 
concentration in the ER of resting -cells is high, about 250 µM. On the ER membranes, 
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there are Ca
2+
 channels and Ca
2+
 pumps that regulate the luminal [Ca
2+
]i. ER is filled with 
Ca
2+
 by sarcoendoplasmic reticulum Ca
2+
 ATPase (SERCA). There is a large amount of 
Ca
2+
 binding proteins in the ER. Calsequestrin is one such Ca
2+
 binding protein in the ER 
lumen. It has a high capacity and low affinity for binding Ca
2+
. Thus, the ER has many 
important players that regulate the [Ca
2+
]i inside the lumen and release Ca
2+
 in response to 
various signals. 
 
  
5.7 Ca2+ channels in the ER 
 
5.7.1 Activation of RyRs and IP3Rs 
There are two main families of Ca
2+
 channels in the ER: the inositol 1,4,5-trisphosphate 
receptors (IP3Rs), and the RyRs. The latter name is derived from the plant alkaloid 
ryanodine, which binds to the receptor with nanomolar affinity, and activates the channel. 
Whereas submicromolar concentrations of ryanodine lock the channel in a long-lived 
open state, micromolar concentrations inhibit the channel. Insulin secretion is stimulated 
by low concentrations (~1 nM) of ryanodine (60). While IP3 activates the IP3 receptor, the 
ryanodine receptor is activated by several mechanisms. Fructose 1,6 diphosphate, 
arachidonic acid, cyclic adenosine diphosphate ribose (cADPr), long chain Acyl CoA, and 
ATP are some of the activators or positive modulators of RyRs (61-63). Caffeine is a 
widely used pharmacological activator of RyRs (64). But caffeine has many non-specific 
effects. Our group has shown that caffeine inhibits the KATP channels, elevates the cAMP 
concentration, and inhibits the L-type voltage-gated Ca
2+
 channels (65). Caffeine also 
inhibits store-operated Ca
2+
 entry (66).  
 
5.7.2 MBED 
Instead of caffeine, we have used 9-methyl 5,7-dibromoeudistomin D (MBED) as a RyR 
activator. MBED is derived from the natural product eudistomin D, isolated from the 
marine tunicate Eudistoma olivaceum (67). MBED has caffeine-like properties, but it is a 
more specific, and more potent activator of RyRs, and is thus more suitable for 
mechanistic studies of these channels (68). It has been suggested that MBED binds to a 
different site than ryanodine on the RyRs, since MBED does not inhibit ryanodine 
binding to the receptor (68). The effects of MBED on RyRs have been known for about 
20 years, and so far no non-specific effect has been reported. We have reported that 
MBED does not inhibit cAMP-phosphodiesterases, IP3Rs, voltage-gated Ca
2+
 channels or 
KATP channels in the -cells (69).  
 
 
5.7.3 Isoforms of RyRs and IP3Rs 
Both IP3Rs and RyRs are present in many cells, and are regulated by positive feedback, 
whereby the released Ca
2+
 can bind to the channel, and increase the Ca
2+
 release. There 
are three isoforms of both channels. The rat insulinoma cell line INS-1 express mRNA for 
IP3R1, IP3R2, and IP3R3, and IP3R1 is in abundance (70). mRNA for all the three 
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isoforms is also found in rat pancreatic islets, rat insulinoma RINm5F cells, and mouse 
insulinoma HC9 cells, but in these cells IP3R1 is in greater abundance (71).  
RyR1 and RyR2 are mainly expressed in the skeletal muscles and heart, respectively, 
while the RyR3 is expressed in the brain, the smooth muscles and the epithelial cells (72). 
All the three isoforms of RyRs, i.e. RyR1, RyR2, and RyR3, are present in human islets 
(73). RyR2, but not RyR1 has been detected by RT-PCR in INS-1 cells, and rat islets 
(29). The RyR2 is mainly located on the ER/SR membranes (74). One group has shown 
that the RyR2 is also expressed on the plasma membrane in the -cells (75).  
 
 
5.8 Store-operated Ca2+ entry 
Store-operated Ca
2+
 entry (SOCE), also called capacitative Ca
2+
 entry, is a process 
whereby the Ca
2+
 entry across the plasma membrane is closely coordinated with the 
depletion of ER Ca
2+
 stores (76). It is conserved from lower organisms such as yeast, 
worms, and flies to human. SOCE has been described in -cells (77). In -cells, as in 
many other cells, an important molecule involved in SOCE is the stromal interaction 
molecule 1 (STIM1) that acts as the Ca
2+
 sensor in the ER. Mammals also have a related 
gene that encodes STIM2. STIM2 is also a Ca
2+
 sensor, but with a different sensitivity for 
the ER Ca
2+
 concentration than STIM1 (78). An intraluminal EF-hand domain of STIM1 
senses the Ca
2+
 concentration in the ER lumen. STIM1 is transported to the plasma 
membrane upon ER Ca
2+
 pool depletion. Orai1, also called CRACM1, is the pore-
forming subunit of a store-operated Ca
2+
 channel in the plasma membrane. This channel 
conducts a highly Ca
2+
-selective, non voltage-gated, inwardly rectifying current, called 
Ca
2+
 release activated Ca
2+
 current (ICRAC) (79). According to one report, ICRAC is 
inhibited when the RyRs are inhibited (80). It is unknown whether STIM1 interacts with 
Orai1 in the -cells. Interaction between STIM1, Orai1, and TRPC might be of 
importance in SOCE (81). One study has shown a connection between the IP3Rs and 
some TRP channels in the plasma membrane (82). Thus, multiple mechanisms may 
underlie different forms of SOCE. 
 
 
5.9 Voltage-gated Ca2+ channels 
In -cells, the most important Ca2+ channels are the ones that are activated upon plasma 
membrane depolarization. Ca
2+
 entry through voltage-gated Ca
2+
 channels triggers 
exocytosis of insulin (83). There are ten voltage-gated Ca
2+
 channels coded by three gene 
families: The Cav1 family has electrical properties of L-type, i.e. they require high voltage 
for activation, and are open for a longer period (“Large and Long”). These channels are 
inhibited by dihydropyridine antagonists. Glucose-induced insulin release is inhibited to 
80-100% by dihydropyridine antagonists (84;85). The main form of L-type voltage-gated 
Ca
2+
 channels in the -cells is Cav1.3 (1D). It is activated at a lower membrane potential 
(~-55mV) compared to Cav1.2 (1C). 
 
The Cav2 family mediates currents of N-, P/Q- or R-type. The P/Q-type Ca
2+
 channels are 
also coupled to insulin secretion, and account for 45% of integrated whole-cell Ca
2+
 
current in human -cells. R-type Ca2+ channels are not present in human -cells (85), but 
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may be involved in insulin secretion through central neurons or GLP-1-producing L-cells 
in the gut (86). There is also the Cav3 family of ion channels that is activated by low 
voltage and have electrical properties of T-type, with smaller and shorter lasting currents 
(“tiny and transient”). The T-type current in human -cells is mediated by Cav3.2 (1G), 
and is involved in insulin release induced by 6 mM but not by 20 mM glucose (85). 
Neither Cav2 nor Cav3 are blocked by dihydropyridine antagonists. We have shown that 
L-type voltage-gated Ca
2+
 channels are activated by membrane depolarization after RyR 
activated Ca
2+
 entry. 
 
  
5.10 Ca2+-induced Ca2+ release 
Ca
2+
-induced Ca
2+
 release (CICR) is an intracellular signaling phenomenon, where a 
[Ca
2+
]i increase triggers Ca
2+
 release from the ER. CICR was first described in the heart 
muscle cells, where a small Ca
2+
 entry trough the L-type voltage-gated Ca
2+
 channels 
caused a large Ca
2+
 release from the SR. This phenomenon takes place in many excitable 
cells, e.g. muscle cells, nerve cells, and the -cells. CICR induces synchronous, transient 
rises in the [Ca
2+
]i that amplifies the Ca
2+
 signals. Both IP3Rs and RyRs are Ca
2+
-gated 
Ca
2+
 channels in the ER (87). In the -cells, activation of RyRs or IP3Rs amplifies Ca
2+
-
dependent exocytosis of insulin by CICR (88;89). GLP-1, a blood-glucose-lowering 
incretin hormone, increase the cAMP in the cytoplasm of the -cells, and facilitates CICR 
by cAMP-dependent phosphorylation of the RyRs (90;91). CICR is also stimulated by 
activation of RyRs by cAMP-regulated guanine nucleotide exchange factors (Epac) in the 
human -cells (92). 
 
 
5.11 Pyridine nucleotide-derived molecules and Ca2+ signaling 
Several reports have demonstrated that glucose elevation increases cyclic ADPr (cADPr) 
and NAADP concentration in the -cells. cADPr is known to stimulate insulin secretion 
in -cells by Ca2+ release from the intracellular Ca2+ stores, and has also been shown to 
activate the TRPM2 channels (31). NAADP releases Ca
2+
 from acidic Ca
2+
 stores, and 
from insulin secretory vesicles (74). A group of voltage-gated ion channels called two-
pore channels (TPCs) are located on the lysosomal membranes, and are activated by 
nanomolar concentrations of NAADP, while micromolar concentrations of NAADP 
inhibit them (93).  
 
ADPr is formed from -NAD+, and NAADP is formed from NADP+ by ADP ribosyl 
cyclases, including CD38 (94). CD38 and its homologues have NADase, ADP-ribosyl 
cyclase, and cADPr hydrolase activities
 
(95). ADPr constitutes more than 99% of the 
products produced by the action of CD38 (96-98). ADPr is also produced by hydrolysis of 
cADPr, and from NAD
+
 by NAD glycohydrolases, (95). Furthermore, poly (ADPr) 
glycohydrolase can produce ADPr from poly (ADPr) (99;100). 
 
Since CD38 is located with its catalytic site oriented extracellularly in the plasma 
membrane (101;102), ADPr produced by CD38 and related enzymes is likely to be 
released extracellularly. Extracellular release of ADPr has been shown in cortical 
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astrocytes (103). Synaptosomes have been reported to have NADase activity, giving rise 
to speculations that ADPr could be a neurotransmitter (104). ADPr is shown to be 
released during nerve stimulation (105).  
 
CD38 and related enzymes are also present in the -cells, and they are thought to play 
some roles in mediating insulin secretion (106). The role of CD38 in insulin secretion is 
generally attributed to RyR activation by cADPr and NAADP (107). It remains unclear 
whether extracellular ADPr can signal by acting on cell surface receptors or whether it 
must enter into the cell. The entrance of ADPr is thought to be via CD38, but the transport 
rate is slow, and this mechanism is not universal (108;109). Ecto-nucleotide 
pyrophosphatases degrade ADPr to AMP (110;111). The conversion of ADPr to AMP 
can also be catalysed by apyrase, and AMP is further metabolized to adenosine by 
5´nucleotidase (112;113). Extracellular ADPr is thus a well-suited nucleotide for 
signaling by activating cell surface receptors. Our studies show that ADPr increase [Ca
2+
]i 
by activation of purinergic receptors of type P2Y1 in the INS-1E cells as well as in the rat 
and human -cells. 
 
 
5.12  Purinergic receptors 
Receptors for purine nucleotides and nucleosides are present in numerous tissues. The 
purinoceptors are classified into P1, which are more specific for adenosine and AMP than 
for ADP and ATP. The adenosine/P1 purinoceptors are in turn divided into A1, A2a, 
A2b, and A3 (114). The A1 and A3 subtypes inhibit adenylate cyclase, while the A2 
subtypes activates adenylate cyclase (115;116).  
 
The P2 purinoceptors are, in contrast, more specific for ATP and ADP than for adenosine 
and AMP. They are divided into P2X and P2Y subtypes, which can be discriminated by 
their response profiles to different ATP-analogues (117). P2X receptors are intrinsic ion 
channels (not G-protein coupled) permeable to Na
2+
, K
+
, and Ca
2+
 (118). P2X receptors in 
the -cells are of subtype P2X1, P2X3, P2X4, P2X6, and P2X7 (119-122). 
 
There are eight human P2Y receptors: P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, 
P2Y13, and P2Y14 (123-125). The missing numbers in the sequence are receptors that are 
cloned from non-mammalian vertebrates or receptors under characterization. The P2 
receptor subtypes in -cells are P2Y1, P2Y2, P2Y4, P2Y6, and P2Y12 (126). The P2Y1 
receptor has been shown to be involved in insulin secretion, but both stimulation of 
insulin secretion and inhibition of secretion have been reported (127). Some studies have 
claimed that P2Y purinoceptors can constitute new targets for antidiabetic drugs 
(128;129). P2Y receptors are G-protein coupled, and often activate the PI-PLC pathway 
leading to IP3 production (130). 
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5.13  The signaling enzyme PI-PLC  
Phosphatidylinositol specific phospholipase C (PI-PLC) constitutes a family of key 
enzymes in the Ca
2+
 signaling. There are eleven isoforms of PI-PLC, and they are divided 
into four families: , , , and . G-protein coupled receptors activate PI-PLC and 
receptor protein-tyrosine kinases activate PI-PLC. Thus, there are many growth 
factors that activate PI-PLCγ. PI-PLC is activated by Ca2+, and PI-PLC is activated by 
GTP-Ras (132). PI-PLC is involved in activation of the GLP-1-receptor-induced 
facilitation of CICR (133). 
 
The PI-PLC enzymes cleave phosphatidyl inositol 4,5-biphosphate (PIP2) to inositol 
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 is a second messenger that binds 
to the IP3 receptor in the ER, and triggers release of Ca
2+
 into the cytoplasm. DAG has 
two signaling roles: it can be cleaved to release arachidonic acid that either works as a 
messenger in its own right, or is used in the synthesis of eicosanoids, such as 
prostaglandins, prostacyclins, tromboxanes, and leukotrienes. DAG activates protein 
kinase C (PKC), and the activation is usually Ca
2+
 dependent (134;135). When the [Ca
2+
]i 
increases, PKC translocates from the cytosol to the cytoplasmic face of the plasma 
membrane, where it is activated by Ca
2+
, DAG, and negatively charged membrane 
phospholipids such as phosphatidylserine. 
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6 Aims of the thesis 
 
The aims of this thesis were to study: 
 
1. the consequences of activation of RyRs on [Ca
2+
]i in pancreatic -cells. 
 
2. whether functional Ca
2+
 permeable TRP-like channels operate in the -cells. 
 
3. whether activation of the RyRs leads to the activation of plasma membrane ion 
channels, and depolarization of the membrane potential. 
 
4. the molecular mechanisms by which ADPr increases [Ca
2+
]i in the insulin-secreting 
cells. 
 
5. whether functional TRPV1 channels are present in the insulin-secreting cells. 
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7 Methods 
7.1 Cells 
In most of the experiments, we used the rat insulinoma cell line INS-1E (subclone S5). 
INS-1E cells are widely used as a model for -cells. The S5 cells were derived from INS-
1E cells in our laboratory, and they differ from the INS-1E cells in that they are adjusted 
to grow in 2.5% FBS while they require a higher concentration of -mercaptoethanol. 
The advantage of using insulinoma cell lines instead of primary -cells is that the cell 
lines consist of pure insulin-secreting cells, whereas cells prepared from islets contain a 
mixture of cells, which cannot be easily identified under microscope. For the 
experiments, cells of round shape that looked like differentiated -cells were chosen. 
Such cells constitute only about 10-20% of the cells in the microscope field. The handling 
of the cells is described in the methods section of each paper. 
 
The use of primary -cells and human islets for experiments was approved by local ethics 
committee. Primary -cells were prepared from the Wistar rat islets. Primary -cells from 
CD1 mice of 12-16 weeks of age were used for insulin secretion studies. The procedures 
for isolation of islets and preparation of -cells are described in the attached papers. 
Human islets were obtained from islet transplantation programmes, and single cells were 
prepared as described in the papers. In paper II, we used 1321N1 human astrocytoma cells 
that stably overexpress human recombinant P2Y1 receptors, and wild type (WT) 
astrocytoma cells that do not express any P2Y1 receptors. 
 
 
7.2  Chemical tools used 
Compound Effects Side effects Used 
concentration 
Paper 
ADP Activates 
purinergic 
receptors 
 30 µM II 
ADP ribose (ADPr) Activates 
TRPM2  
 30 µM II 
2-aminoethoxy-
diphenyl borate  
(2-APB) 
Inhibits ICRAC 
and activates 
TRPV1-3 
Inhibits IP3R and 
some TRP 
channels, 
including 
TRPC1,3-6 
Inhibits 
SERCA (136) 
30 µM I 
Arachidonic acid Activates many 
TRP channels 
and RyRs 
 5 µM III 
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8-Bromo-ADPr  ADPr antagonist  30 µM II 
cADPr Activates RyR 
(?) 
Activates 
TRPM2 
30 µM II 
Capsaicin Activates 
TRPV1 
 300 nM III 
Capsazepine Inhibits TRPV1  10 µM III 
Carbachol (cch) Muscarinic 
agonist 
 
10-100 µM I, II, III 
2-chloro N6-
methyl-(N)-
methanocarba-2-
deoxyadenosine- 
3,5-bisphosphate 
(MRS 2279) 
Inhibits P2Y1 
receptor  
Not reported 10 µM II 
2´Deoxy-N6-
methyladenosine 
3,5-bisphosphate 
(MRS 2179) 
Inhibits P2Y1 
receptor  
Inhibits P2X1 
receptor (137)  
1-10 µM II 
Diazoxide Opens KATP 
channels 
 100 µM I 
Gadolinium 
chloride (GdCl3) 
Blocks several 
TRP channels, 
including 
TRPC1,3,6, 
TRPM3,4, 
TRPV4, TRPP1, 
TRPML1 
Inhibits 
voltage-gated 
Ca
2+
 channels 
and stretch-
activated 
channels 
(138;139) 
10 µM I 
Lanthanium 
chloride (LaCl3) 
Blocks several 
TRP channels, 
including 
TRPC3-7, 
TRPV2,4-6, 
TPRM4,7, 
TRPP1, 
TRPML1 
Activates 
TRPC3 and 5 
in µM 
concentrations. 
100 µM I 
9-methyl 5,7-
dibromoeudistomin 
D (MBED) 
RyR activation Not reported 50 µM I 
Nimodipine Blocks L-type 
voltage-gated 
Ca
2+
 channels 
 5 µM I 
NAD
+
 Activates 
TRPM2 through 
conversion to 
ADPr 
 
 30 µM II 
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Niflumic acid Inhibits TRP 
channels, 
including 
TRPC4,6, 
TRPM2,3, and 
TRPV4 
(140;141) 
 50 µM I 
Nimodipine Blocks L-type 
voltage-gated 
Ca
2+
 channels 
 5 µM I 
N-(4-
hydroxyphenyl)-
5,8,11,14-
eicosatetraenamide 
(AM404) 
Activates 
TRPV1 
 5 µM III 
N-(p-amylcinna-
moyl) anthranilic 
acid (ACA) 
Inhibits TRPM2 Inhibits 
TRPM8 and 
TRPC6 (142) 
20 µM II 
N-propargyl-
nitrendipene  
(MRS 1845) 
Blocks SOCE  5 µM I 
O-acetyl adenosine 
diphosphate 
ribose (OAADPr) 
Actylated 
analogue of 
ADPr, activates 
TRPM2 (143) 
 10 µM II 
PADPr Stable analogue 
of ADPr 
 100 µM II 
p-aminophenol Metabolite of 
paracetamol 
 5 µM III 
 
Potassium chloride 
(KCl) 
Depolarization of 
plasma 
membrane 
 25 mM I, II, III 
Ruthenium red 
(RR) 
Blocks RyRs and 
TRP channels, 
including 
TRPC3, TRPV1-
6, TRPM3,6, and 
TRPA1 
Many 
nonspecific 
effects 
10 µM I 
Ryanodine Activates (nM) 
and inhibits 
(µM) RyR 
 50 µM I 
SKF 96365 Inhibits several 
TRP cannels 
including 
TRPC6, 7 and 
TRPV2.  
Inhibits 
voltage-gated 
Ca
2+
 channels 
and SOCE. 
10 µM I 
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Thapsigargin Inhibits SERCA   125-500 nM I, II, III 
U73122 Inhibits PI-PLC  10 µM II 
 
 
7.3 Measurements of [Ca2+]i by microfluorometry  
It is nowadays common to use fluorescence techniques to measure [Ca
2+
]i in single living 
cells in real time. The measurement is done by use of a variety of fluorescent Ca
2+ 
indicators. For measurement of [Ca
2+
]i, fura-2 is the most commonly used indicator. The 
fluorescence ratio between the free and the Ca
2+
-bound forms of fura-2 enables one to 
calculate the [Ca
2+
]i. Since fura-2 is cell-impermeant, an acetoxymethyl (AM) ester is 
coupled to the carboxylate groups of fura-2 to enable penetration through the cell 
membrane. Once inside the cell, the AM-group is hydrolyzed by the intracellular 
esterases, and fura-2 becomes Ca
2+
-sensitive.  
 
The fluorescence of fura-2 at 340 nm increases about threefold and at 380 nm decreases 
about tenfold upon Ca
2+
-binding. The emission maximum of fura-2 is at 510 nm. [Ca
2+
]i is 
calculated from F340/F380 according to Grynkiewicz et al (144). Rmax and Rmin were 
determined in our studies by using external standards containing fura-2 free acid and 
sucrose (2 M) (145). The method is described in detail in paper I, II, and III. 
 
 
7.4 Electrophysiology 
Patch clamp-recordings enable measurement of the electrical potential or the electrical 
current across the cell membrane. It is possible to isolate currents through a specific class 
of channels by adjustment of the ionic composition of the extracellular and intracellular 
solutions, application of pharmacological inhibitors etc. There are several modes of patch 
clamp, depending on whether single channels or a group of channels are going to be 
studied. 
 
All patch clamp experiments start in the cell-attached patch mode. A tight contact 
between the recording pipette and the cell is accomplished by light suction to the pipette 
interior. A high shunt resistance (> 1 gigaohm) is produced. This is called a giga-seal. The 
cell is still intact. We used the pore-forming agent amphotericin B to perforate the cell 
membrane. This is called perforated patch whole-cell configuration. Physical contact with 
the cell interior is thus established. The advantage of the perforated-patch whole cell 
method is that there is no washout of intracellular compounds, since the pores only allow 
passage of small monovalent ions but not larger molecules or ions such as Ca
2+
 (146). In 
this way, it is a more physiological configuration than the standard whole-cell 
configuration, where the membrane rupture is achieved by a pulse of negative pressure by 
gentle suction. 
 
For current measurements, we used a fully automated patch clamp workstation (Port-a-
patch, Nanion, Munich, Germany) equipped with an HEKA EPC 10 amplifier (HEKA, 
Lambrecht/Pfalz, Germany). The planar patch clamp glass chip containing a micron sized 
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aperture was primed by adding 5 µl of internal and external solution to the respective 
sides of the chip. The PatchControl software (Nanion Technologies, Munich, Germany) 
applied a suction protocol to automatically capture a cell, obtain a giga-seal between the 
glass substrate and the cellular membrane, and eventually obtain whole cell voltage 
clamp configuration. Details are written in the respective papers. 
 
 
7.5  Measurement of insulin secretion 
The use of islets from mice was approved by the local ethics committee. Islets from mice 
pancreas were isolated as described by Kelly et al (147). After 24 h incubation and 
recovery from the isolation procedure, the cells were dispersed by trypsin (0.25%) for 8 
min to obtain single cells. Total separation of the cells was verified microscopically, and 
the cells were transferred to multi-well plates (2×10
5
 cells/well). For attachment, the cells 
were incubated for 24 h in 11 mM glucose. A washing procedure repeated three times 
with KRBH containing 3.3 mM glucose, and 15 min of preincubation in 3.3 mM glucose 
preceded the stimulation. According to the different treatments tested, the wells were 
divided into 4 groups. Group 1 was incubated with 3.3 mM glucose, group 2 with 16.7 
mM glucose, group 3 with 3.3 mM glucose and 80 µM ADPr, and group 4 was incubated 
with 16.7 mM glucose and 80 µM ADPr. Insulin concentration in the collected samples 
was measured by ELISA using a commercial kit (Crystal Chem Inc).  
 
 
7.6  Whole-blood flow cytometric assays 
The experiments were approved by local ethics committee. We tested blood from three 
individuals between the ages of 24 and 42. Venous blood was collected by venepuncture. 
Within 5 min of blood collection, the blood samples were processed for flow cytometric 
measurements. We used whole-blood flow cytometry to evaluate the effect of ADPr on 
platelet shape change, aggregability (fibrinogen binding), and secretion (P-selectin 
expression). Whole-blood flow cytometric assays of platelet P-selectin expression and 
fibrinogen binding have been described previously (148). Platelets were gated by their 
characteristic light scattering signals, and the gated cells were confirmed with fluorescein 
isothiocyanate (FITC) conjugated anti-CD42a (GPIX) monoclonal antibody (MAb) Beb1 
(Becton Dickinson, San Jose, CA, USA). Please see details in paper II on how the 
platelet shape change was monitored. Platelet shape change was expressed as percentage 
calculated according to the following formula: % of platelet shape change=100×((platelet 
counts within the innergate after stimulation-platelet counts within the innergate before 
stimulation)/(platelet counts within the inner gate before stimulation)). 
 
 
7.7 Western blot analysis 
Western blot was used to study the expression of TRPV1 protein in the INS-1E cells and 
in the human islets. The primary anti-TRPV1 antibody used was affinity-purified rabbit 
polyclonal IgG antibody (BIOMOL international, U.K., BML-SA564-0050, Lot # 
P9604a, cat. no. SA-6564). The antibody was directed against the peptide sequence 
DASTRDRHATQQEEV, which represents the amino acid residues 824-838 in the C-
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terminal region of the rat TRPV1. The specific blocking peptide antigen (TRPV1 
blocking peptide, BIOMOL international, U.K., BML-SA564-0050, Lot #P9604a, SA-
564) was used to test the specificity of the antibody. Please see detailed information of 
the procedures in paper III.  
 
 
7.8 Immunohistochemistry 
 
Immunohistochemistry was used to detect TRPV1 protein in the human islet cells and the 
human insulinoma cells. Human pancreas resection specimens were collected from the 
Laboratory of Pathology at the Uppsala University Hospital, Sweden. They were from 
surgical specimens that were stored in the biobank after approval from the local ethics 
committee. The samples were fixed in formalin and embedded in paraffin wax. Sections 
from the tissue microarray blocks were cut at 4 μm thickness and immunostained. 
Primary antibodies and a dextran polymer visualization system (UltraVision LP HRP 
polymer®, Lab Vision) were incubated for 30 min each at RT. Diaminobenzidine (Lab 
Vision) was used as chromogen, and slides were developed for 10 min. For details of the 
immunostaining procedures, please see paper III.  
 
We used eight different antibodies that were affinity purified rabbit polyclonal IgG 
antibodies raised against synthetic peptides corresponding to either the C-terminus or the 
N-terminus of TRPV1. The antibodies were from: 1. Biosensis (cat. no. R-076-100), 2. 
Alomone (cat. no. ACC-03), 3. Sigma (cat. no. V2764), 4. and 5. Santa Cruz 
Biotechnologies (cat. no. Sc-20813 and Sc-28759), 6. and 7. Chemicon (cat. no. AB5889 
and AB5370P) and 8. the human protein atlas project (HRPK2180179, not published in 
the Protein Atlas, yet). 
 
 
7.9 Statistical analysis 
The data were expressed as means ± SEM. When comparison between two groups was 
made, Student’s unpaired t-test was used, and when comparison was made within groups 
paired t-test was used. The p-value was considered as significant when <0.05. The 
concentration-response curves were made by using Graph Pad software. 
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8 Results and discussion 
 
The detailed results of experiments and discussions of their interpretation and importance 
are in the two published papers and one manuscript that constitute this thesis. In the 
following paragraphs, I shall briefly mention only the results of some of the key 
experiments.  
 
8.1 RyRs operate activation of TRP-like channels 
RyRs amplify Ca
2+
 signals by CICR and thereby increase insulin secretion 
(63;74;89;149). However, any possible role of RyRs in triggering Ca
2+
 entry through the 
plasma membrane remained unknown. Many groups have used caffeine to activate RyRs, 
but caffeine inhibits many ion channels, enzymes, and receptors. It also inhibits KATP 
channels, voltage-gated Ca
2+
 channels, and store operated Ca
2+
 channels (65;66). We used 
a more specific agonist of RyR, namely MBED, to study the consequences of RyR 
activation in the -cells. 
 
In paper I, we showed that MBED activated RyRs in the -cells and elicited a pattern of 
[Ca
2+
]i increases that could be divided into three distinct components. First, there was an 
initial peak, which declined to a plateau phase with regenerative spikes superimposed on 
the plateau (fig. 3). We found that the different phases of [Ca
2+
]i increases were due to 
different underlying mechanisms. The initial peak was present even when the 
extracellular Ca
2+
 was omitted, but was abolished when the ER Ca
2+
 pools were depleted 
by thapsigargin, a specific inhibitor of the SERCA (150). Thus, the initial peak was due to 
a transient Ca
2+
 release from the ER caused by RyR activation. These results were in 
accordance with earlier studies (69;151).  
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Figure 3. Activation of RyRs elicited a characteristic pattern of [Ca
2+
]i changes. 
The figure is reproduced from Jabin Gustafsson et al 2004. MBED activated the RyRs 
in INS-1E cells, which resulted in a characteristic pattern of changes in [Ca
2+
]i. After 
addition of MBED (50µM) in the presence 10 mM glucose, there was an initial rapid 
rise of [Ca
2+
]i, which declined to a plateau. A series of large [Ca
2+
]i spikes were 
superimposed on the [Ca
2+
]i plateau. 
 
 
 
 
 
The plateau phase was the most important finding in this study. It was abolished by 
omission of extracellular Ca
2+
, and by SKF 96365, an inhibitor of SOCE and several TRP 
channels (152;153). Hence, we concluded that RyR activation also led to a prolonged 
[Ca
2+
]i increase that was due to Ca
2+
 entry through some TRP-like Ca
2+
 channels in the 
plasma membrane. In comparison to the carbachol-induced capacitative Ca
2+
 entry 
(SOCE), the RyR-operated Ca
2+
 influx was much larger. When the cells were treated with 
thapsigargin, there was still a [Ca
2+
]i plateau after stimulation by MBED. This suggests 
that the Ca
2+
 influx through the plasma membrane was not entirely dependent on the 
filling state of the ER. Instead, protein-protein interactions and conformational coupling 
could possibly be the link between activation of RyRs in the ER and the activation of 
Ca
2+
 channels in the plasma membrane. Such gating of the putative TRP channels by 
RyRs has previously been reported in other systems (154;155).  
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Figure 4. LaCl3, niflumic acid, and 2-APB inhibited the [Ca
2+
]i plateau that 
followed the activation of RyRs. The figures are reproduced from Jabin Gustafsson et 
al 2004. Activation of RyRs by MBED (50 µM) in the continued presence of LaCl3 
(100 µM) (B) or niflumic acid (50 µM) (C) caused the initial rise of [Ca
2+
]i, but the 
plateau phase of [Ca
2+
]i increase was inhibited. The plateau phase was also inhibited by 
2-APB (30 µM) (D). 
 
 
 
 
 
More recently, Rosker et al have reported that the Ca
2+
 entry in the plateau phase is 
mediated by RyR2 located on the plasma membrane (75). However, the reported currents 
do not mimic any earlier reported currents of RyRs (156;157). It has been suggested that 
the channels described by Rosker et al, may represent a novel, non-selective ion-channel 
(158). In our study, the Ca
2+
 entry was blocked by SKF 96365, a compound that does not 
block RyRs. Therefore, it is unlikely that the Ca
2+
 entry was due to RyR in the plasma 
membrane. To rule out whether the plateau phase was due to activation of voltage-gated 
Ca
2+
 channels, nimodipine was used. But nimodipine did not inhibit the Ca
2+
 plateau. 
La
3+
, Gd
3+
, SKF 96365, niflumic acid, and 2-APB are non-selective inhibitors of different 
channels including several TRP channels (159;160), and they all inhibited the Ca
2+
 
plateau. These results suggest that the plateau phase was due to activation of some Ca
2+
 
channels belonging to the TRP family. 
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The third pattern of changes in [Ca
2+
]i was the regenerative spikes that were superimposed 
on the plateau phase. Our results demonstrated that after activation of the RyR, the plasma 
membrane was depolarized to about -40 mV as a result of Ca
2+ 
entry through the putative 
TRP-like channels. Such depolarization in turn activated the L-type voltage-gated Ca
2+
 
channels. Since the spikes were inhibited by nimodipine, they required Ca
2+
 entry through 
the L-type voltage-gated channels. Also, the spikes were caused by CICR through the 
RyRs, as evidenced by the fact that high concentrations of ryanodine inhibited the spikes.  
 
After the paper was published, we studied whether the plateau phase was due to the 
activation of TRPM2 or TRPV1, two TRP channels that we identified in the INS-1E cells. 
But neither ACA, a specific inhibitor of TRPM2, nor capsazepine, a specific inhibitor of 
TRPV1, were able to inhibit the plateau phase (data not shown). Thus, the identity of the 
TRP-like channels that mediate the Ca
2+
 entry in response to the activation of the RyRs 
remains unclear. Transcripts for several TRP channels have been found in the -cells. 
Also, the possibility of different types of TRP forming homo- and heterotetramers yields 
many optional channels (161). 
 
Under physiological conditions, the glucose metabolism is sensed by RyRs through 
molecules such as cADPr and fructose 1,6 diphosphate, among others. When the RyRs 
are activated, this will lead to [Ca
2+
]i increase by activation of the putative TRP channels, 
membrane depolarization, and activation of L-type voltage-gated Ca
2+
 channels. The 
[Ca
2+
]i increase will trigger exosytosis of insulin (fig. 5). It is of great importance that the 
role of TRP channels in Ca
2+
 signaling in the -cells is elucidated and its physiological 
importance further investigated.  
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Figure 5. Schematic diagram of hypothesized involvement of RyRs and TRP-like 
channels in Ca
2+ 
entry and membrane depolarization in -cells. The figure is 
reproduced from Jabin Gustafsson et al 2005: The cartoon illustrates a sequence of 
events, whereby activation of RyRs (A) leads to the activation of TRP-like channels 
(B), an initial -membrane depolarization to about -40 mV (C), activation of the L-type 
voltage-gated Ca
2+
 channels (D), CICR (E), and exocytosis of insulin (F). 
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8.2 Extracellular ADPr activates P2Y1 receptors  
 
Our study on the effect of ADPr on [Ca
2+
]i in the -cells was a side track from the main 
focus of this thesis. During our search for TRP channels in the -cells we used ADPr as a 
tool to activate TRPM2, and to our surprise we found that extracellular ADPr increases 
[Ca
2+
]i in the -cells. This effect of ADPr was so obvious that we decided to identify the 
cell surface receptor involved in mediating the [Ca
2+
]i response. ADPr increased [Ca
2+
]i in 
a concentration-dependent manner (EC50 of ~ 30 µM). The [Ca
2+
]i increase was observed 
in the INS-1E cells, as well as in the primary rat and human -cells. Our first suspicion 
was that commercially available ADPr might contain ADP as a contaminant, which could 
elicit the observed [Ca
2+
]i increase. Therefore, we synthesized highly purified ADPr that 
was free from ADP, but still similar [Ca
2+
]i increase by ADPr was observed. The 
concentration of ADPr required for [Ca
2+
]i increase in our experiments was much higher 
than that of ADP, the cognate agonist of P2Y1 receptors. The EC50 for ADP-induced 
activation of the P2Y1 receptor is 1 µM (162). However, ADPr concentrations in the 
range of 30 µM have been used in the past to demonstrate biological effects of ADPr in 
different tissues (112;163-166). It is possible that the concentration of ADPr at its local 
sites of actions is in the micromolar range, but we do not have any proof for that. 
 
NAD
+
, cADPr or breakdown products of ADPr did not increase [Ca
2+
]i. Neither PADPr, a 
phosphonate analogue of ADPr, nor 8-bromo-ADPr, increased [Ca
2+
]i. Non of them 
altered the ADPr-induced [Ca
2+
]i changes.  
 
ADPr increased [Ca
2+
]i in the form of an initial peak followed by a plateau that depended 
on extracellular Ca
2+
. Such biphasic [Ca
2+
]i increase resembles the [Ca
2+
]i changes upon 
activation of receptors coupled to PI-PLC. When the ER Ca
2+
 pool was depleted by 
thapsigargin, the [Ca
2+
]i increase was abolished, indicating that the [Ca
2+
]i rise was due to 
release of Ca
2+
 from the ER. Furthermore, this [Ca
2+
]i increase was abolished by the PI-
PLC inhibitor U73122, and by 2-APB, which inhibits the IP3 receptor. These results 
suggest that the ADPr-induced [Ca
2+
]i increase was due to activation of the PI-PLC-IP3 
pathway.  
 
When Ca
2+
 was omitted from the extracellular medium, the plateau phase of the ADPr-
induced [Ca
2+
]i increase was abolished, indicating that this phase was due to Ca
2+
 entry 
from outside the cell. The plateau phase was not inhibited by inhibitors of TRPM2, 
namely flufenamic acid, niflumic acid, and ACA. Inhibition of the L-type voltage-gated 
Ca
2+
 channels also did not inhibit the plateau phase. These results indicate lack of 
involvement of both TRPM2 channels and L-type voltage-gated Ca
2+
 channels in 
mediating the Ca
2+
 entry. 
 
The most important findings in this study were that MRS 2179 and MRS 2279, two 
specific inhibitors of the purinergic receptor P2Y1 (167;168), completely blocked the 
ADPr-induced [Ca
2+
]i increase (fig. 6). MRS2279 only inhibits P2Y1, but MRS2179 also 
inhibits P2X1 and P2X3 (137). These results are strong evidence for the involvement of 
the P2Y1 receptor in the ADPr-induced [Ca
2+
]i increase. 
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To further establish that we were dealing with P2Y1 receptors, we used 1321N1 human 
astrocytoma cells that stably overexpress human P2Y1 receptors. ADPr increased [Ca
2+
]i 
in these cells, but did not increase [Ca
2+
]i in the wild type astrocytoma cells that do not 
express P2Y1 receptors. Biological effects of ADPr-induced [Ca
2+
]i increase were tested 
in the platelets, which express native P2Y1 receptors. ADPr induced platelet shape 
change as a result of [Ca
2+
]i increase through P2Y1 activation. 
 
The role of P2Y1 in insulin secretion is controversial. Depending on experimental 
conditions, cell types used, choice of P2Y1 agonist and its dosage, P2Y1 activation can 
either increase or inhibit the insulin secretion (169-172). The [Ca
2+
]i increase leading to 
the insulin secretion is mainly due to Ca
2+
 entry through the voltage gated Ca
2+
 channels 
(85). In our study ADPr did not alter the basal or glucose-induced insulin secretion. We 
conclude that ADPr is a novel endogenous and specific agonist of P2Y1 receptors that 
increases the [Ca
2+
]i in the insulin-secreting cells (fig. 7). The physiological importance of 
this finding needs further investigations. 
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Figure 6. ADPr-induced [Ca
2+
]i increase was due to the activation of P2Y1 receptors. 
The figure is reproduced from Jabin Gustafsson et al 2011. The INS-1E cells were 
incubated for 10 min with either MRS 2179 (1 and 10 µM) (B) or MRS 2279(10 µM) (C). 
The inhibitors were also present in the perfusion during the experiment. Both MRS2179 
and MRS2279 completely inhibited the [Ca
2+
]i increase by ADPr (10 µM). Fig. A is a 
control experiment that shows ADPr-induced [Ca
2+
]i increase in the absence of the 
inhibitors. MRS2179 and MRS2279 did not block the carbachol- induced [Ca
2+
]i increase. 
The traces are representatives of at least three experiments each.  
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Figure 7. Schematic figure of ADPr as a ligand of the P2Y1 receptor. Extracellular 
ADPr activates the P2Y1 receptor (P2Y1R) and the PI-PLC, leading to the formation of 
IP3 produced from PIP2. The IP3R is activated, and Ca
2+
 is released from the ER.  
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8.3 INS-1E cells express functional TRPV1 channels 
In paper III, we studied whether -cells have functional TRPV1 channels. We tested 
whether TRPV1 activation leads to [Ca
2+
]i increase. Capsaicin, a specific agonist of 
TRPV1, increased [Ca
2+
]i in the INS-1E cells in a concentration-dependent manner. The 
[Ca
2+
]i increase was dependent on extracellular Ca
2+
.These results indicated that we were 
dealing with Ca
2+
 channels in the plasma membrane. AM404, another known TRPV1 
agonist, also increased [Ca
2+
]i in the INS-1E cells. However, the precursors p-aminopenol 
and arachidonic acid did not increase [Ca
2+
]i. Capsazepine, a specific inhibitor of TRPV1, 
completely blocked both the capsaicin-induced and the AM404-induced [Ca
2+
]i increase. 
These results together suggest that TRPV1 channels are located in the plasma membrane 
in the INS-1E cells, and causes Ca
2+
 entry and [Ca
2+
]i increase upon activation. 
 
Capsaicin elicited inward currents in the INS-1E cells, and the currents were inhibited by 
capsazepine. Since the permeability of TRPV1 is higher for Ca
2+ 
than for Na
+
 
(PNa
+
/PCa
2+
 = 1:9) (24), Ca
2+
 was probably the main carrier of the current in our 
experiments. This is consistent with microfluorometry experiments where capsaicin 
induced robust increase in [Ca
2+
]i. 
 
The expression of TRPV1 protein in the INS-1E cells and the human islets was detected 
by Western blot analysis. The bands that were seen at ~94 kDa in the INS-1E cells and at 
~96 kDa in the human islets were compared with the expected molecular weight of 
TRPV1 estimated from the mRNA. According to the comparison, the bands represented 
TRPV1. Our results were also in accordance with several earlier studies (173-177).  
 
The existence of TRPV1 in primary -cells is debated. Akiba et al have demonstrated 
TRPV1 immunoreactivity in primary β-cells from Sprague-Dawley rats, but they did not 
report the effect of capsaicin in these cells (35). Gram et al reported TRPV1 
immunoreactivity in the nerve fibres in the islets, but not in the β-cells (51). In our study, 
we used primary β-cells from Wistar rat, but capsaicin did not induce any [Ca2+]i increase 
in these cells. These results suggest that primary -cells do not have TRPV1 channels. 
 
The existence of TRPV1 in human β-cells is questionable. In our study, capsaicin did not 
increase [Ca
2+
]i in human β-cells. Also, no TRPV1 immunoreactivity was detected in the 
human islets or human insulinoma cells. We used eight different antibodies that all 
detected TRPV1 immunoreactivity in the dorsal root ganglion cells, which were used as 
controls. Thus, TRPV1 is not expressed in the human β-cells, at least not at as high level 
as in the dorsal root ganglion cells. We conclude that functional TRPV1 channels are 
expressed at high level in the INS-1E cells, but not in the primary -cells from rat or 
human. 
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Figure 8. Effect of capsaicin and capsazepine on [Ca
2+
]i in the INS-1E cells. The 
figure is reproduced from Jabin Fågelskiöld et al 2011. Capsaicin (300 nM) increased 
[Ca
2+
]i (A). In the presence of capsazepine (10 μM), capsaicin failed to increase [Ca
2+
]i 
(B).  
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9 Conclusions 
 
1. The activation of RyRs induces a series of distinct signaling events, which include 
release of Ca
2+
 from the ER, activation of putative Ca
2+
-permeable TRP-like channels in 
the plasma membrane, membrane depolarization, Ca
2+
 entry through the voltage-gated 
Ca
2+
 channels, and regenerative CICR. 
  
2. Extracellular ADPr increases [Ca
2+
]i in the insulin-secreting cells by activation of the 
P2Y1 purinergic receptors. 
 
3. Functional Ca
2+
 permeable TRPV1 channels are present in the INS-1E cells, but not in 
the primary rat or human -cells or the human insulinoma cells. 
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10  Future perspectives 
 
It is important to identify which TRP channels are present and functional in the -, -, 
and -cells of the islets. Several TRP channels have already been identified in the -cells 
and their role in the Ca
2+
 signaling and stimulus-secretion coupling needs to be studied in 
detail. The TRP channels might play an important role in mediating the depolarizing 
currents that lead to depolarization to the threshold for activation of the voltage-gated 
Ca
2+
 channels. Diverse physical second messengers like heat, swelling, stretch, and 
chemical factors like arachidonic acid, cAMP, PIP2, and Ca
2+
 could act as links between 
insulin-secretagogues and activation of the TRP-channels. One of the challenges in the 
future will be to investigate the quantitative contribution of different second messengers 
and different TRP channels in stimulus-secretion coupling in the -cells under different 
physiological and pathological conditions. The availability of more specific 
pharmacological tools and use of TRP channel knock-out mice models will hopefully give 
answers to many of the remaining questions. Eventually, some of these TRP channels 
may turn out to be molecular targets for the development of drugs for the treatment of 
impaired insulin secretion in diabetes.   
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